Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT05123079 | Relative Bioavailability and Food Effect Following Single Oral Dose of Darigabat Tablet Formulations in Healthy Participants | PHASE1 | COMPLETED | 12 | — | — | Nov 1, 2021 | Dec 1, 2021 | Jan 20, 2022 | - | — |
| Name | Type | Description |
|---|---|---|
| Darigabat | DRUG | Tablets |